BioXcel Therapeutics Rings the Closing Bell
About This Event
BioXcel Therapeutics (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Vimal Mehta, CEO, rings the Closing Bell.